
handok pharmaceuticals
Yakult Honsha Initiates Perifosine Phase I/II Trial For Colorectal Cancer in Japan
Aeterna Zentaris’ partner, Yakult Honsha, has initiated a Phase I/II trial in Japan assessing the use of perifosine in combination with capecitabine for the treatment of colorectal cancer.
